---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-298474"
form_type: "8-K"
ticker: "ELVN"
cik: "0001672619"
company_name: "Enliven Therapeutics, Inc."
filed_at: "2022-12-05T23:59:59+00:00"
generated_at: "2026-06-21T09:39:32.056722+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Imara Inc. announces expiration of HSR Act waiting period for merger with Enliven Therapeutics

## Summary
- HSR Act waiting period for merger with Enliven Therapeutics expired on Nov 28, 2022, without extension or request for additional information.
- This expiration satisfies one of the conditions to closing the merger previously announced on Oct 13, 2022.
- Upon closing, Merger Sub will merge with Enliven, making Enliven a wholly-owned subsidiary of Imara.

## SEC filing metadata
- accession: 0001193125-22-298474
- form_type: 8-K
- ticker: ELVN
- cik: 0001672619
- company_name: Enliven Therapeutics, Inc.
- filed_at: 2022-12-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1672619/000119312522298474/0001193125-22-298474-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1672619/000119312522298474/d415058d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-298474
- JSON: https://secwatch.observer/filing/0001193125-22-298474.json
- Plain text: https://secwatch.observer/filing/0001193125-22-298474.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.